Pieris Pharmaceuticals In... (PIRS)
NASDAQ: PIRS
· Real-Time Price · USD
13.60
-2.51 (-15.58%)
At close: Dec 13, 2024, 10:00 PM
Pieris Pharmaceuticals Ratios and Metrics
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
PE Ratio | -0.05 | -1.25 | -1.9 | -0.88 | -0.95 | -0.98 | -0.68 | 0.91 | -1.48 | -2.4 | -2.51 | -3.35 | -20.34 | -7.44 | -5.29 | -3.82 | -8.67 |
PEG Ratio | 0.00 | 0.01 | 0.09 | 0.03 | -0.15 | 0.02 | 0.00 | -0.01 | -0.03 | 0.45 | 0.14 | -0.01 | 0.29 | 0.16 | 2.12 | -0.02 | 0.12 |
PS Ratio | n/a | -571.18 | n/a | n/a | 349.16 | 13.87 | 1.51 | 0.72 | 37.57 | 13.24 | 15.93 | 37.45 | 20.33 | 32.29 | 86.31 | 72.18 | 9.25 |
PB Ratio | 0.03 | 0.48 | 1.35 | 0.67 | 0.84 | 0.67 | 0.97 | 0.36 | 4.71 | 2.77 | 2.39 | 3.12 | 4.18 | 5.37 | 6.50 | 5.07 | 3.78 |
P/FCF Ratio | -0.22 | -12.06 | 149.90 | -8.51 | -2.65 | -0.92 | -3.01 | -1.07 | -6.59 | -5.55 | -9.71 | -8.54 | -9.7 | -24.16 | -23.61 | 7.99 | -11.89 |
P/OCF Ratio | -0.22 | -12.06 | 149.90 | -8.51 | -2.65 | -0.92 | -3.03 | -1.08 | -6.61 | -5.99 | -9.75 | -8.89 | -9.86 | -24.91 | -24.18 | 7.93 | -11.92 |
OCF/S Ratio | n/a | 47.36 | n/a | n/a | -132 | -15.14 | -0.5 | -0.67 | -5.68 | -2.21 | -1.63 | -4.21 | -2.06 | -1.3 | -3.57 | 9.10 | -0.78 |
Debt / Equity Ratio | n/a | n/a | n/a | n/a | n/a | n/a | 0.40 | 0.32 | 0.79 | 0.47 | 0.34 | 0.30 | 0.27 | 0.29 | 0.29 | 0.34 | 0.42 |
Quick Ratio | 8.84 | 7.33 | 4.82 | 3.95 | 3.92 | 3.24 | 1.97 | 1.93 | 1.41 | 2.01 | 2.34 | 2.56 | 2.83 | 2.52 | 2.77 | 2.91 | 2.92 |
Current Ratio | 8.84 | 7.33 | 4.82 | 3.95 | 3.92 | 3.24 | 2.05 | 1.93 | 1.41 | 2.01 | 2.34 | 2.56 | 2.83 | 2.52 | 2.77 | 2.91 | 2.92 |
Asset Turnover | n/a | -0.00 | n/a | n/a | 0.00 | 0.03 | 0.33 | 0.23 | 0.02 | 0.06 | 0.05 | 0.03 | 0.08 | 0.05 | 0.02 | 0.02 | 0.14 |
Interest Coverage | n/a | -3.25 | n/a | n/a | n/a | -2.35 | n/a | n/a | n/a | n/a | n/a | n/a | -2.49K | -1.83K | n/a | n/a | n/a |
Return on Equity | -0.15 | -0.1 | -0.18 | -0.19 | -0.22 | -0.17 | -0.35 | 0.10 | -0.8 | -0.29 | -0.24 | -0.23 | -0.05 | -0.18 | -0.31 | -0.33 | -0.11 |
Return on Assets | -0.1 | -0.07 | -0.14 | -0.14 | -0.17 | -0.12 | -0.18 | 0.05 | -0.15 | -0.08 | -0.09 | -0.09 | -0.02 | -0.06 | -0.1 | -0.1 | -0.04 |
Return on Invested Capital | n/a | 0.17 | -0.19 | -0.22 | -0.24 | -0.17 | -0.21 | 0.04 | -0.36 | -0.19 | -0.16 | -0.15 | -0.04 | -0.1 | -0.16 | -0.15 | -0.06 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | -12.6 | n/a | n/a | 1.57 | -2.43 | 0.96 | 0.96 | 0.71 | 0.90 | 0.86 | -2.23 | 0.92 | 0.93 | -3.67 | -3.81 | -0.06 |
Net Profit Margin | n/a | 114.43 | n/a | n/a | -92.3 | -3.53 | -0.55 | 0.20 | -6.36 | -1.38 | -1.59 | -2.8 | -0.25 | -1.08 | -4.08 | -4.72 | -0.27 |
Pretax Profit Margin | n/a | 114.43 | n/a | n/a | -92.3 | -3.53 | -0.55 | 0.20 | -6.81 | -1.39 | -1.81 | -2.8 | -0.46 | -1.13 | -4.08 | -4.72 | -0.27 |
Operating Profit Margin | n/a | -238.02 | n/a | n/a | -100.06 | -4.22 | -0.6 | 0.10 | -8.01 | -1.97 | -2.27 | -3.33 | -0.68 | -1.3 | -4.69 | -5.1 | -0.32 |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | 185.82 | n/a | n/a | -100.06 | -3.53 | 0.20 | 0.23 | -6.51 | -1.29 | -1.67 | -2.64 | -0.39 | -1.1 | -3.93 | -4.54 | -0.28 |